Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureMohammed Wattad, J Krauter, Verena I. Gaidzik et al.|Leukemia|2017Cited by 118
Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Peter Paschka et al.|Journal of Clinical Oncology|2019Cited by 111